Skip to content

A prospective and retrospective two-way cohort study of arthroscopic acetabular labral reconstruction and acetabular labral dissection in the treatment of severe acetabular labral injury

A prospective and retrospective two-way cohort study of arthroscopic acetabular labral reconstruction and acetabular labral dissection in the treatment of severe acetabular labral injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099966
Enrollment
Unknown
Registered
2025-04-01
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Acetabular Labral Injuries

Interventions

Acetabular Labrum Debridement Group:None
Iliotibial Band Reconstruction Group:None
Hamstring Tendon Reconstruction Group:None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age: Adults aged 18-50 years 2. Patients with chronic pain in the hip joint, with poor results of conservative treatment such as exercise adjustment/topical drugs/oral non-steroidal anti-inflammatory drugs for more than 3 months 3. Patients with severe labral injury (labral absence or width < 3 mm, labral parenchymal degeneration with cyst formation, extensive labral calcification) confirmed by hip MRI, who are not expected to be repaired with sutures before surgery, and need to be cleaned/reconstructed 4. The patient voluntarily participates in the clinical trial, signs the informed consent form, and is able to cooperate with the completion of clinical follow-up.

Exclusion criteria

Exclusion criteria: 1. Those who have participated in clinical trials of other drugs or medical devices within the last 6 months 2. History of previous ipsilateral hip surgery 3. Patients who underwent bilateral surgery at the same time 4. Patients with moderate to severe hip dysplasia: there are signs of insufficient acetabular coverage such as LCEA 15°; 5. Patients with moderate to severe osteoarthritis: Tönnis grade > 2 6. Combined with hip-specific synovitis (such as rheumatoid synovitis, gouty synovitis, pigmented villonodular synovitis, etc.)

Design outcomes

Primary

MeasureTime frame
Modified Harris Hip Score (MHHS);International Hip Outcome Tool-12(iHOT-12);Patient-Reported Outcome (PRO); Visual Analog Scale (VAS);MRI imaging criteria;Knee Injury and Osteoarthritis Outcome Score (KOOS) ;

Countries

China

Contacts

Public ContactHongjie Huang

Peking University Third Hospital

bysyhhj@163.com+86 135 0017 4894

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026